In a 25-year-old woman with obesity and PCOS, severe hypoglycemia (35 mg/dL) developed after she started semaglutide; the authors attribute it to an underlying insulinoma.
In plain wordsIn one young woman, very low blood sugar followed the start of semaglutide. The authors link it to an insulin-making tumor.
- Peptide
- Semaglutide
- Outcome
- Not applicableSevere hypoglycemia after starting semaglutide
- Study
n = 1
- Outcome group
- Adverse events · Endocrine and hormones
- Studied dose
- Dose not stated
Measurements
- Blood glucose
- 35 mg/dL
- case patient
Source sentences
A 25-year-old woman with obesity and polycystic ovary syndrome (PCOS) developed severe hypoglycemia (35 mg/dL) after starting semaglutide.
1 context sentence(design, population, supporting numbers)
This case emphasizes that hypoglycemia occurring during GLP-1 receptor agonist therapy is not always a drug-related side effect but may result from unmasking of an underlying insulinoma.